NEW FILINGS<\/p>\n Company: Y-mAbs Therapeutics, Inc. Company: Arco Platform Limited Company: Bank7 Corp. Company: Livent Corporation Company: Alzheon, Inc. Company: X Financial Company: Viomi Technology Co., Ltd. Company: SVMK, Inc. (SurveyMonkey) Company: Sutro Biopharma, Inc. Company: Arvinas, Inc UPDATED TERMS<\/p>\n Company: NIO Inc. Company: 111, Inc. This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-4844","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4844"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4844\/revisions"}],"predecessor-version":[{"id":4848,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4844\/revisions\/4848"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/08\/pipeline1-300x207.jpg\")
<\/a>![\"\"](\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/08\/pipeline2-300x243.jpg\")
<\/a><\/p>\n
\nSymbol: YMAB
\nDescription: They are a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): BofA Merrill Lynch, Cowen, Canaccord Genuity
\nCo-Manager(s): BTIG
\nFiled: 8-24-18
\nListed Cash Raise: $92m<\/p>\n
\nSymbol: ARCE
\nDescription: They provide a complete pedagogical system with technology-enabled features to deliver educational content to private schools in Brazil.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: Goldman Sachs, Morgan Stanley, Itau BBA, BofA Merrill Lynch, Allen & Co., BTG Pactual, UBS
\nFiled: 8-24-18
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: BSVN
\nDescription: They are Bank7 Corp., a bank holding company headquartered in Oklahoma City, Oklahoma.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: Keefe Bruyette & Woods, Stephens Inc., Sandler O’ Neill
\nFiled: 8-24-18
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: LTHM
\nDescription: They are a pure-play, fully integrated lithium company, with a long, proven history of producing performance lithium compounds.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: BofA Merrill Lynch, Goldman Sachs, Credit Suisse
\nCo-Manager(s): Citigroup, Loop Capital, Nomura
\nFiled: 8-27-18
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ALZH
\nDescription: They are a clinical stage biopharmaceutical company with a Phase 3-ready program in Alzheimers disease and a discovery platform of small molecules for the inhibition of protein misfolding in neurodegenerative disorders.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: ThinkEquity
\nWithdrawn: 5-1-18
\nRe-Filed: 8-27-18
\nListed Cash Raise: $40.25<\/p>\n
\nSymbol: XYF
\nDescription: They are a leading technology-driven personal finance company in China focused on serving China’s underserved prime borrowers and mass affluent investor.
\nNew York.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters :Deutsche Bank, Morgan Stanley
\nCo-Manager(s): China Merchant Securities
\nFiled: 8-28-18
\nListed Cash Raise: $250m<\/p>\n
\nSymbol: VIOT
\nDescription: They have developed a unique IoT @ Home platform, consisting of an ecosystem of innovative IoT-enabled smart home products, or IoT products, together with a suite of complementary consumable products and value-added businesses.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: Morgan Stanley, CICC
\nFiled: 8-28-18
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: SVMK
\nDescription: They are a leading global provider of survey software products that enable organizations to engage with their key constituents, including their customers, employees and the markets they serve.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: J.P. Morgan, Allen & Company, BofA Merrill Lynch, Credit Suisse, UBS Investment Bank, Wells Fargo Securities
\nCo-Manager(s): SunTrust Robinson Humphrey, CODE Advisors, Foros, JMP Securities, LionTree
\nFiled: 8-29-18
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: STRO
\nDescription: They are a clinical stage drug discovery, development and manufacturing company focused on leveraging our proprietary integrated cell-free protein synthesis platform, XpressCF, to create a broad variety of optimally designed, next-generation protein therapeutics for cancer and autoimmune disorders.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: Cowen, Piper Jaffray
\nCo-Manager(s): JMP Securities, Wedbush PacGrow
\nFiled: 8-29-18
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: ARVN
\nDescription: They are a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriters: Goldman Sachs, Citigroup, Piper Jaffray
\nFiled: 8-30-18
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: NIO
\nDescription: They are a pioneer in China\u2019s premium electric vehicle market.
\nNew York.
\nTrade Date: 9\/12
\nShares: 160 million ADSs
\nPrice Range: $6.25-$8.25
\nUnderwriter(s): Morgan Stanley, Goldman Sachs (Asia), J.P. Morgan, BofA Merrill Lynch Deutsche Bank, Citigroup, Credit Suisse, UBS Investment Bank
\nCo-Manager: Wolfe Capital
\nFiled: 8-28-18<\/p>\n
\nSymbol: YI
\nDescription: They provide hundreds of millions of consumers with better access to pharmaceutical products and medical services, directly through their online retail pharmacy and indirectly through their offline pharmacy network.
\nTrade Date: 9\/12
\nShares: 9.3 million ADSs
\nPrice Range: $14.00-$16.00
\nUnderwriter(s): J.P. Morgan, Citigroup, CICC
\nTerms Added: 8-29-18<\/p>\n","protected":false},"excerpt":{"rendered":"